<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">KJO</journal-id>
      <journal-title-group>
        <journal-title>Korean Journal of Ophthalmology : KJO</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8942</issn>
      <publisher>
        <publisher-name>The Korean Ophthalmological Society</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20046693</article-id>
      <article-id pub-id-type="pmc">2789957</article-id>
      <article-id pub-id-type="doi">10.3341/kjo.2009.23.4.301</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Trichilemmal Carcinoma of the Upper Eyelid: A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Ju Hyang</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shin</surname>
            <given-names>Yong Woon</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oh</surname>
            <given-names>Young Ha</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Yoon Jung</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Ophthalmology, Hanyang University School of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Pathology, Hanyang University Guri Hospital, Hanyang University School of Medicine, Guri, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Ophthalmology, Hanyang University Guri Hospital, Hanyang University School of Medicine, Guri, Korea.</aff>
      <author-notes>
        <corresp>
Reprint requests to Yoon Jung Lee, MD. Department of Ophthalmology, Hanyang University Guri Hospital, 249-1, Gyomun-dong, Guri-city, Gyeonggi-do 471-710, Korea. Tel: 82-31-560-2350, Fax: 82-31-564-9479, <email>lyjot@hanyang.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>04</day>
        <month>12</month>
        <year>2009</year>
      </pub-date>
      <volume>23</volume>
      <issue>4</issue>
      <fpage>301</fpage>
      <lpage>305</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>1</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>11</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2009 by the Korean Ophthalmological Society</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report a very rare case of trichilemmal carcinoma (TLC) involving the upper eyelid. To the best of our knowledge, this is the first report of trichilemmal carcinoma of the upper eyelid in Korea. A 51-year-old man presented to our hospital complaining of a bloody discharge from his left upper eyelid. He had a soft and lobulated mass on the palpebral conjunctiva. An incisional biopsy revealed trabecular growth of tumor cells with clear cytoplasm, prominent nucleoli, frequent mitoses, and foci of trichilemmal keratinization. Immunohistochemically, the lesion was positive for p53 and negative for CD 34. A diagnosis of TLC was made, and total excision of the mass and reconstruction of the eyelid were performed. Trichilemmal carcinoma is a rare malignant tumor, though it appears to be an indolent neoplasm with no metastatic potential. The treatment of choice for trichilemmal carcinoma of the eyelid is complete excision with tumor-free margins due to the locally invasive nature of the lesion.</p>
      </abstract>
      <kwd-group>
        <kwd>Eyelid</kwd>
        <kwd>Trichilemmal carcinoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Trichilemmal carcinoma (TLC) is an uncommon malignant adnexal tumor that originates from the external hair sheath.<xref ref-type="bibr" rid="B1">1</xref> Trichilemmal carcinoma has a benign clinical course, but exhibits a malignant and invasive histological appearance.<xref ref-type="bibr" rid="B2">2</xref> Eyelid involvement of TLC has been only rarely reported. Here, we report the first Korean case of TLC involving the upper eyelid.</p>
    <sec sec-type="cases">
      <title>Case report</title>
      <p>A 51-year-old man presented with bloody discharge from his left upper eyelid that had begun 2 to 3 days prior to presentation. One month prior to visiting our hospital, he had noticed the presence of a nontender, palpable, movable nodule that had not changed in size since discovery (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Swelling of the left upper lid was apparent.</p>
      <p>Slit-lamp examination revealed a 0.5&#xD7;0.5 cm-sized protruding lesion of the left upper palpebral conjunctiva. The mass was slightly yellow and was composed of multiple lobules (<xref ref-type="fig" rid="F2">Fig. 2</xref>). An incisional biopsy was performed.</p>
      <p>On incisional biopsy, a yellowish solid mass was observed. The mass demonstrated a trabecular growth pattern of tumor cell nests characterized by clear cytoplasm, prominent nucleoli, frequent mitoses, few atypical tripolar mitoses, and focal necrosis. There were also foci of trichilemmal keratinization (<xref ref-type="fig" rid="F3">Fig. 3</xref>). On immunohistochemical staining, the tumor cells were diffusely distributed and were strongly positive for p53, but were negative for CD 34 (<xref ref-type="fig" rid="F4">Fig. 4</xref>). Given the histological and immunohistochemical findings, the lesion was determined to be a TLC.</p>
      <p>The mass was completely excised with a pentagonal wedge resection of the upper lid, including a 5-mm safety margin, and the eyelid was reconstructed. The mass lesion was first outlined in a pentagonal shape and then excised; the excision included the surrounding palpebral conjunctiva. Tumor-free margins were ensured by frozen section analysis (<xref ref-type="fig" rid="F5">Fig. 5A</xref>). The posterior lamella was reconstructed with a sliding tarsoconjunctival flap, and the anterior lamella was repaired with a myocutaneous advancement flap (<xref ref-type="fig" rid="F5">Fig. 5B-5D</xref>). After completion of the procedure, a reverse Frost suture was inserted into the center of the upper eyelid to prevent corneal exposure.</p>
      <p>At the six month follow-up, there was no evidence of local recurrence or metastasis.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Trichilemmal carcinoma was first described in 1976 as "a histologically invasive, cytologically atypical, clear cell neoplasm of adnexal keratinocytes which is in continuity with the epidermis and/or follicular epithelium."<xref ref-type="bibr" rid="B3">3</xref> In most patients, the tumor typically occurs on sun-exposed areas of the face and scalp,<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref> but is rare on the eyelid.<xref ref-type="bibr" rid="B5">5</xref> Trichilemmal carcinoma on the eyelid was first described in 1993 in a 95-year-old woman.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref></p>
      <p>Trichilemmal carcinoma typically affects individuals aged 40 years and older.<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref> Trichilemmal carcinoma can have a grossly papular, nodular, or exophytic appearance.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref> All TLCs reported to date have been less than 2 cm in diameter.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref> Lai and colleagues<xref ref-type="bibr" rid="B10">10</xref> reported an induration of the eyelid with a small area of ulceration and keratosis, but a normal conjunctiva. In previous reports,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref> there were no significant changes of the conjunctiva; in the current case however, the upper lid mass completely penetrated into the inner side of the upper lid and was seen on the conjunctival side on slit-lamp examination.</p>
      <p>Histopathologically, TLC demonstrates a lobular proliferation centered on pilosebaceous structures and is composed of clear cells that are characterized by clear cytoplasm and prominent nucleoli. Trichilemmal carcinoma exhibits trichilemmal keratinization with an abrupt or pagetoid interface and dermal invasion.<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref></p>
      <p>Malignant proliferating trichilemmal tumors (PTTs) are often confused with TLC. However, PTT is not synonymous with TLC.<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B9">9</xref> Proliferating trichilemmal tumors usually arise in a pre-existing trichilemmal cyst and are frequently confined to the scalp. Proliferating trichilemmal tumors are larger than TLCs (with a diameter of up to 25 cm). Proliferating trichilemmal tumors demonstrate sharply circumscribed convoluted lobules with pushing margins, deep dermal extensions, extensive areas of tumor cell necrosis, abrupt keratinization, minimal pleomorphism, low mitotic activity, and foci indistinguishable from a trichilemmal cyst.<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref> Proliferating trichilemmal tumors are apt to recur and to metastasize, as distinct from the behavior of TLCs.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B9">9</xref></p>
      <p>Trichilemmal carcinoma must be differentiated from other skin cancers. It is easy to confuse TLC with clear cell basal cell carcinoma (BCC), but zones of clear cells are not sufficient to diagnosis conventional BCC.<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref> Squamous cell carcinoma demonstrates cellular atypia and cells with clear cytoplasm, similar to TLC, but differs from TLC in the absence of trichilemmal keratinization or lobular proliferation.<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B10">10</xref> Also, TLC resembles trichilemmoma in the presence of a plate-like endophytic nodule extending into the dermis, but differs with respect to the occurrence of frequent mitosis or cellular atypia.<xref ref-type="bibr" rid="B1">1</xref></p>
      <p>p53 tumor suppressor gene mutations are often found in patients with nonmelanoma skin cancer. Complete loss of p53 on immunohistochemical staining represents the malignant transformation of PTT.<xref ref-type="bibr" rid="B11">11</xref> Also, focal staining for the presence of CD 34 is a marker of differentiation from the outer hair sheath. However, the tumor of the current patient was negative for CD 34, indicating an undifferentiated tumor cell type.<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref></p>
      <p>Trichilemmal carcinoma is locally invasive and, histologically, appears to have high-grade mitotic potential. However, TLC generally has a benign clinical course, and there is no evidence of recurrence after complete excision.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref></p>
      <p>Masayuki et al.<xref ref-type="bibr" rid="B11">11</xref> reported a case of TLC of the upper eyelid that was treated with full dose irradiation. However, the tumor recurred and invaded the orbit. The tumor was resected in a procedure involving the eyelid and orbital contents. At the 29 month follow-up, there was no evidence of local recurrence or metastasis.</p>
      <p>Consequently, upon presentation of an indurated nodule or an ulcerated mass on the eyelid, it is necessary to consider the possibility of a cancerous lesion.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref> Trichilemmal carcinoma should be considered in the differential diagnosis of an eyelid mass. Trichilemmal carcinoma is a malignant tumor that usually does not metastasize, despite local regional recurrence.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B14">14</xref> It is important to perform a total excision of the tumor mass, with tumor-free margins, and to offer careful follow-up to all patients.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="presented-at">
        <p>This paper was presented in part at the 99th annual meeting of the Korean Ophthalmological Society, April, 2008</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Billingsley</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Davidowski</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Maloney</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Trichilemmal carcinoma</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>107</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="pmid">8996274</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reis</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Tellechea</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Baptista</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Trichilemmal carcinoma: review of 8 cases</article-title>
          <source>J Cutan Pathol</source>
          <year>1993</year>
          <volume>20</volume>
          <fpage>44</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">8468416</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Headington</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Tumour of the hair follicle: a review</article-title>
          <source>Am J Pathol</source>
          <year>1976</year>
          <volume>85</volume>
          <fpage>479</fpage>
          <lpage>514</lpage>
          <pub-id pub-id-type="pmid">793411</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Min</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>SY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Trichilemmal carcinoma with a cutaneous horn</article-title>
          <source>Br J Dermatol</source>
          <year>2000</year>
          <volume>143</volume>
          <fpage>646</fpage>
          <lpage>647</lpage>
          <pub-id pub-id-type="pmid">10971347</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dailey</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Helm</surname>
              <given-names>KF</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Tricholemmal carcinoma of the eyelid</article-title>
          <source>Am J Ophthalmol</source>
          <year>1993</year>
          <volume>115</volume>
          <fpage>118</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">8420367</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Malignant proliferating trichilemmal tumor of the lower eyelid</article-title>
          <source>Ophthal Plast Reconstr Surg</source>
          <year>2005</year>
          <volume>21</volume>
          <fpage>349</fpage>
          <lpage>352</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boscaino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Terrancciano</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Donofrio</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Trichilemmal carcinoma: a study of seven cases</article-title>
          <source>J Cutan Pathol</source>
          <year>1992</year>
          <volume>19</volume>
          <fpage>94</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">1375954</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swanson</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Marrogi</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>DJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tricholemmal carcinoma: a clinicopathologic study of 10 cases</article-title>
          <source>J Cutan Pathol</source>
          <year>1992</year>
          <volume>19</volume>
          <fpage>100</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="pmid">1597565</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>KO</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Baladas</surname>
              <given-names>HG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiple tumour presentation of trichilemmal carcinoma</article-title>
          <source>Br J Plast Surg</source>
          <year>1999</year>
          <volume>52</volume>
          <fpage>665</fpage>
          <lpage>667</lpage>
          <pub-id pub-id-type="pmid">10658141</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lai</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Huilgol</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>CL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Trichilemmal carcinoma of the upper eyelid</article-title>
          <source>Acta Ophthalmol Scand</source>
          <year>2003</year>
          <volume>81</volume>
          <fpage>536</fpage>
          <lpage>538</lpage>
          <pub-id pub-id-type="pmid">14510806</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masayuki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hideo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yurihisa</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Surgical treatment of recurrent trichilemmal carcinoma of the upper eyelid</article-title>
          <source>Otolaryngol Head Neck Surg (Tokyo)</source>
          <year>2004</year>
          <volume>76</volume>
          <fpage>709</fpage>
          <lpage>713</lpage>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takata</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rehman</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rees</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>A trichilemmal carcinoma arising from a proliferating trichilemmal cyst: the loss of the wild-type p53 is a critical event in malignant transformation</article-title>
          <source>Human Pathology</source>
          <year>1998</year>
          <volume>29</volume>
          <fpage>193</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">9490283</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poblet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jimenez-Acosta</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rocamora</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>QBEND/10 (anti-CD34 antibody) in external root sheath cells and follicular tumours</article-title>
          <source>J Cutan Pathol</source>
          <year>1994</year>
          <volume>21</volume>
          <fpage>224</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">7525669</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herrero</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Monteagudo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ruiz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Llombart-Bosch</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Malignant proliferating trichilemmal tumours: an histopathological and immunohistochemical study of three cases with DNA ploidy and morphometric evaluation</article-title>
          <source>Histopathology</source>
          <year>1998</year>
          <volume>33</volume>
          <fpage>542</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="pmid">9870149</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>The patient had a swelling of the upper eyelid and a palpable, nontender, movable mass on the left eyelid.</p>
      </caption>
      <graphic xlink:href="kjo-23-301-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>A yellowish, soft, multi-lobulated mass is shown. The mass protrudes through the lateral end of the left upper palpebral conjunctiva. (A) Gross view. (B) Slit-lamp view.</p>
      </caption>
      <graphic xlink:href="kjo-23-301-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>Histology of the mass. (A) The section revealed a trabecular growth pattern of tumor cell nests (H&amp;E, &#xD7;40). (B, C) The cells were characterized by clear cytoplasm, prominent nucleoli, frequent mitoses, few atypical tripolar mitoses, and focal necrosis. There were also foci of trichilemmal keratinization (black arrow) (B: H&amp;E, &#xD7;100; C: H&amp;E, &#xD7;400).</p>
      </caption>
      <graphic xlink:href="kjo-23-301-g003"/>
    </fig>
    <fig id="F4" position="float">
      <label>Fig. 4</label>
      <caption>
        <p>Immunohistochemical staining of the mass. (A) Negative staining for CD 34. (B) Strongly positive staining for p53.</p>
      </caption>
      <graphic xlink:href="kjo-23-301-g004"/>
    </fig>
    <fig id="F5" position="float">
      <label>Fig. 5</label>
      <caption>
        <p>Mass excision and reconstruction of the defect. (A) Complete mass excision using a pentagonal shape. Tumor-free margins were confirmed by frozen section biopsy. (B) Reconstruction of the posterior lamella with a tarsoconjunctival sling. (C) Reconstruction of the anterior lamella with a myocutaneous advancement flap. (D) Complete closure of the defect.</p>
      </caption>
      <graphic xlink:href="kjo-23-301-g005"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
